REPLIGEN CORP Financing Cash Flow
REPLIGEN CORP (RGEN) reported Financing Cash Flow of -$11.74 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-07-29
- REPLIGEN CORP net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$6.20M.
- REPLIGEN CORP net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$5.54M.
- REPLIGEN CORP net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $195.00K, a 86.54% decline year-over-year.
- REPLIGEN CORP net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$239.00K.
- REPLIGEN CORP net cash provided by (used in) financing activities for fiscal 2025 was -$15.21M.
- REPLIGEN CORP net cash provided by (used in) financing activities for fiscal 2024 was -$82.90M, a 133.30% decline from fiscal 2023.
- REPLIGEN CORP net cash provided by (used in) financing activities for fiscal 2023 was $248.96M.
- REPLIGEN CORP net cash provided by (used in) financing activities for fiscal 2022 was -$13.34M, a 1487.83% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$6.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$11.74M 10-Q · filed 2026-07-29 | -$11.55M derived: sum of 3 quarters · filed 2026-07-29 | -$11.79M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | -$5.54M 10-Q · filed 2026-05-06 | -$5.35M derived: sum of 2 quarters · filed 2026-05-06 | -$5.59M derived: sum of 3 quarters · filed 2026-05-06 | -$15.72M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $195.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$44.00K derived: sum of 2 quarters · filed 2026-02-26 | -$10.18M derived: sum of 3 quarters · filed 2026-07-29 | -$15.21M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$239.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$10.37M derived: sum of 2 quarters · filed 2026-07-29 | -$15.40M 10-Q · filed 2025-11-04 | -$13.95M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | -$10.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$15.16M 10-Q · filed 2026-07-29 | -$13.71M derived: sum of 3 quarters · filed 2026-07-29 | -$83.32M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | -$5.03M 10-Q · filed 2026-05-06 | -$3.58M derived: sum of 2 quarters · filed 2026-05-06 | -$73.19M derived: sum of 3 quarters · filed 2026-05-06 | -$78.96M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$68.16M derived: sum of 2 quarters · filed 2026-02-26 | -$73.93M derived: sum of 3 quarters · filed 2026-02-26 | -$82.90M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$69.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$75.38M derived: sum of 2 quarters · filed 2025-11-04 | -$84.35M 10-Q · filed 2025-11-04 | $183.78M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$5.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$14.75M 10-Q · filed 2025-08-07 | $253.38M derived: sum of 3 quarters · filed 2026-02-26 | $252.60M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$8.97M 10-Q · filed 2025-04-29 | $259.15M derived: sum of 2 quarters · filed 2026-02-26 | $258.38M derived: sum of 3 quarters · filed 2026-02-26 | $249.55M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $268.13M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-26 | $267.35M derived: sum of 2 quarters · filed 2026-02-26 | $258.52M derived: sum of 3 quarters · filed 2026-02-26 | $248.96M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$778.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18 | -$9.60M derived: sum of 2 quarters · filed 2024-11-18 | -$19.17M 10-Q/A · filed 2024-11-18 | -$19.44M derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-06-30 | -$8.82M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | -$18.39M 10-Q/A · filed 2024-11-18 | -$18.66M derived: sum of 3 quarters · filed 2025-03-14 | -$17.41M derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-03-31 | -$9.56M 10-Q/A · filed 2024-11-18 | -$9.84M derived: sum of 2 quarters · filed 2025-03-14 | -$8.59M derived: sum of 3 quarters · filed 2025-03-14 | -$10.88M derived: sum of 4 quarters · filed 2025-03-14 |
| 2022-12-31 | -$274.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-03-14 | $977.00K derived: sum of 2 quarters · filed 2025-03-14 | -$1.32M derived: sum of 3 quarters · filed 2025-03-14 | -$13.34M 10-K · filed 2025-03-14 |
| 2022-09-30 | $1.25M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18 | -$1.04M derived: sum of 2 quarters · filed 2024-11-18 | -$13.06M 10-Q/A · filed 2024-11-18 | -$12.83M derived: sum of 4 quarters · filed 2024-11-18 |
| 2022-06-30 | -$2.29M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | -$14.31M 10-Q/A · filed 2024-11-18 | -$14.08M derived: sum of 3 quarters · filed 2024-11-18 | -$14.21M derived: sum of 4 quarters · filed 2024-11-18 |
| 2022-03-31 | -$12.02M 10-Q/A · filed 2024-11-18 | -$11.79M derived: sum of 2 quarters · filed 2024-11-18 | -$11.91M derived: sum of 3 quarters · filed 2024-11-18 | -$11.57M derived: sum of 4 quarters · filed 2024-11-18 |
| 2021-12-31 | $231.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18 | $109.00K derived: sum of 2 quarters · filed 2024-11-18 | $454.00K derived: sum of 3 quarters · filed 2024-11-18 | $961.00K 10-K/A · filed 2024-11-18 |
| 2021-09-30 | -$122.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $223.00K derived: sum of 2 quarters · filed 2022-11-01 | $730.00K 10-Q · filed 2022-11-01 | $299.57M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $345.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $852.00K 10-Q · filed 2022-08-02 | $299.69M derived: sum of 3 quarters · filed 2023-02-22 | $301.37M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $507.00K 10-Q · filed 2022-04-27 | $299.35M derived: sum of 2 quarters · filed 2023-02-22 | $301.02M derived: sum of 3 quarters · filed 2023-02-22 | $304.83M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $298.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $300.51M derived: sum of 2 quarters · filed 2023-02-22 | $304.33M derived: sum of 3 quarters · filed 2023-02-22 | $305.92M 10-K · filed 2023-02-22 |
| 2020-09-30 | $1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $5.49M derived: sum of 2 quarters · filed 2021-10-28 | $7.08M 10-Q · filed 2021-10-28 | $6.90M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-30 | $3.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | $5.40M 10-Q · filed 2021-07-27 | $5.22M derived: sum of 3 quarters · filed 2022-02-17 | $300.10M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-31 | $1.59M 10-Q · filed 2021-05-04 | $1.41M derived: sum of 2 quarters · filed 2022-02-17 | $296.28M derived: sum of 3 quarters · filed 2022-02-17 | $486.41M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-31 | -$180.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $294.69M derived: sum of 2 quarters · filed 2022-02-17 | $484.82M derived: sum of 3 quarters · filed 2022-02-17 | $484.87M 10-K · filed 2022-02-17 |
| 2019-09-30 | $294.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $485.00M derived: sum of 2 quarters · filed 2020-11-05 | $485.05M 10-Q · filed 2020-11-05 | $486.09M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $190.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $190.17M 10-Q · filed 2020-07-30 | $191.22M derived: sum of 3 quarters · filed 2021-02-24 | $192.10M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $44.00K 10-Q · filed 2020-05-06 | $1.09M derived: sum of 2 quarters · filed 2021-02-24 | $1.97M derived: sum of 3 quarters · filed 2021-02-24 | $3.12M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $1.93M derived: sum of 2 quarters · filed 2021-02-24 | $3.07M derived: sum of 3 quarters · filed 2021-02-24 | $3.41M 10-K · filed 2021-02-24 |
| 2018-09-30 | $884.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $2.03M derived: sum of 2 quarters · filed 2019-10-31 | $2.36M 10-Q · filed 2019-10-31 | $2.67M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $1.48M 10-Q · filed 2019-08-01 | $1.78M derived: sum of 3 quarters · filed 2020-02-26 | $131.60M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $333.00K 10-Q · filed 2019-05-09 | $636.00K derived: sum of 2 quarters · filed 2020-02-26 | $130.45M derived: sum of 3 quarters · filed 2020-02-26 | |
| 2017-12-31 | $303.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $130.12M derived: sum of 2 quarters · filed 2020-02-26 | $129.94M 10-K · filed 2020-02-26 | |
| 2017-09-30 | $129.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $129.64M 10-Q · filed 2018-11-01 | ||
| 2017-06-30 | -$172.00K 10-Q · filed 2018-08-02 | |||
| 2016-12-31 | $112.11M 10-K · filed 2019-03-01 | |||
| 2013-12-31 | $286.91K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $487.64K derived: sum of 2 quarters · filed 2014-03-14 | $1.57M derived: sum of 3 quarters · filed 2014-03-14 | $2.52M 10-K · filed 2014-03-14 |
| 2013-09-30 | $200.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $1.28M derived: sum of 2 quarters · filed 2013-11-08 | $2.24M 10-Q · filed 2013-11-08 | $2.51M derived: sum of 4 quarters · filed 2014-03-14 |
| 2013-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $2.03M 10-Q · filed 2013-08-07 | $2.31M derived: sum of 3 quarters · filed 2014-03-14 | $3.06M derived: sum of 4 quarters · filed 2014-03-14 |
| 2013-03-31 | $956.72K 10-Q · filed 2013-05-07 | $1.23M derived: sum of 2 quarters · filed 2014-03-14 | $1.98M derived: sum of 3 quarters · filed 2014-03-14 | $2.00M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-12-31 | $272.36K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $1.02M derived: sum of 2 quarters · filed 2014-03-14 | $1.05M derived: sum of 3 quarters · filed 2014-03-14 | $1.16M 10-K · filed 2014-03-14 |
| 2012-09-30 | $751.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $773.16K derived: sum of 2 quarters · filed 2013-11-08 | $886.70K 10-Q · filed 2013-11-08 | $886.70K derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | $21.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $134.99K 10-Q · filed 2013-08-07 | $134.99K derived: sum of 3 quarters · filed 2014-03-14 | -$195.85K derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | $113.54K 10-Q · filed 2013-05-07 | $113.54K derived: sum of 2 quarters · filed 2014-03-14 | -$217.30K derived: sum of 3 quarters · filed 2014-03-14 | -$217.30K derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | $0.00 derived: 10-K 9 month − 10-Q 6 month · filed 2014-03-14 | -$330.84K derived: sum of 2 quarters · filed 2014-03-14 | -$330.84K 10-K · filed 2014-03-14 | -$350.03K derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-09-30 | -$330.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$330.84K 10-Q · filed 2011-11-09 | -$350.03K 10-Q · filed 2012-11-08 | -$406.88K derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$19.19K 10-Q · filed 2012-08-09 | -$76.04K derived: sum of 3 quarters · filed 2014-03-14 | -$67.03K derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-03-31 | -$19.19K 10-Q · filed 2012-05-10 | -$76.04K derived: sum of 2 quarters · filed 2014-03-14 | -$67.03K derived: sum of 3 quarters · filed 2014-03-14 | -$50.28K 10-K · filed 2013-03-15 |
| 2010-12-31 | -$56.85K derived: 10-K 9 month − 10-Q 6 month · filed 2014-03-14 | -$47.84K derived: sum of 2 quarters · filed 2014-03-14 | -$31.09K 10-K · filed 2014-03-14 | |
| 2010-09-30 | $9.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-09 | $25.76K 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | $16.75K 10-Q · filed 2011-08-05 | |||
| 2010-03-31 | $11.59K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |